+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Next-Generation Sequencing Services Market Outlook 2026-2034: By Application, Service Type, Technology, End User

  • PDF Icon

    Report

  • 160 Pages
  • November 2026
  • Region: Global
  • OG Analysis
  • ID: 6242369
UP TO OFF until Jan 01st 2027
The Next-Generation Sequencing Services Market is estimated at USD 6.6 billion in 2026 and is projected to reach USD 18.2 billion by 2034, growing at a CAGR of 13.5% during 2026-2034.

Market Overview

The Next-Generation Sequencing Services Market covers outsourced sequencing and related laboratory services that support research, diagnostics, biomarker studies, and clinical development through advanced genomic workflows. Clinical and research sequencing projects support outsourced service demand. Short-read and long-read methods require different sample and analysis workflows.

Data interpretation, turnaround and sample quality constrain service delivery. Specialized panels and longitudinal projects offer repeat business. Laboratory clusters in North America, Europe and Asia-Pacific compete for projects. Customers compare execution capability, service continuity and clearly defined responsibilities. Pricing needs to reflect the resources and conditions involved in delivering the agreed scope. Contracts differ with operating conditions and customer requirements. Standard service packages and specialist assignments can require different staffing, planning and performance measures. Customers require relevant qualifications and consistent execution. Clear documentation and defined acceptance criteria help connect delivered work with the agreed service scope.

Key Takeaways

  • Demand drivers: Clinical and research sequencing projects support outsourced service demand. Recurring contracts and project assignments can follow different scheduling, resource and revenue patterns. Customers assess whether service capacity can meet the agreed scope under actual operating conditions.
  • Technology and performance: Short-read and long-read methods require different sample and analysis workflows. Tools and information systems support delivery but do not replace the relevant practical expertise. Clear responsibilities, practical scheduling and dependable reporting help maintain continuity and support informed decisions about contract renewal or expansion.
  • Challenges and economics: Data interpretation, turnaround and sample quality constrain service delivery. Contract scope and response expectations need to be realistic for the conditions in which work is performed.
  • Commercial opportunities: Specialized panels and longitudinal projects offer repeat business. Specialist expertise can address work that customers cannot readily undertake themselves. Dependable execution and clear responsibilities support repeat engagements and longer-term relationships.
  • Geographic considerations: Laboratory clusters in North America, Europe and Asia-Pacific compete for projects. Customer locations and local service capacity shape regional opportunities. Staffing, travel requirements and relevant operating rules affect how providers serve different markets.
  • Product and segment distinctions: Application coverage includes Clinical Diagnostics, Drug Discovery & Development, Biotechnology & Genetic Research and Other Applications. Contracts differ with operating conditions and customer requirements. Standard service packages and specialist assignments can require different staffing, planning and performance measures.
  • Application and customer priorities: Service Type categories include Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-Based Sequencing Services and Gene Regulation Services. Customers require relevant qualifications and consistent execution. Clear documentation and defined acceptance criteria help connect delivered work with the agreed service scope.
  • Purchasing and delivery: Clients compare assay scope, accreditation and usable analytical outputs. Procurement evaluates staffing, scheduling and response capability. Reliable communications and clear reporting help customers manage service delivery alongside their own operations.
  • Competitive positioning: Eurofins Scientific, Quest Diagnostics and Labcorp are among the companies covered. The analysis distinguishes relevant product, technology and channel roles, with emphasis on application fit, supply capabilities and customer support.
  • Outlook priorities: The next-generation sequencing services outlook depends on the interaction of end-use demand, product qualification and commercially viable delivery. Specialized panels and longitudinal projects offer repeat business. Laboratory clusters in North America, Europe and Asia-Pacific compete for projects.

Competitive Landscape

The next-generation sequencing services competitive landscape includes Eurofins Scientific, Quest Diagnostics, Labcorp and BGI Genomics, alongside the other companies named in this report. Customers compare execution capability, service continuity and clearly defined responsibilities. Pricing needs to reflect the resources and conditions involved in delivering the agreed scope. Customers require relevant qualifications and consistent execution. Clear documentation and defined acceptance criteria help connect delivered work with the agreed service scope. Procurement evaluates staffing, scheduling and response capability. Reliable communications and clear reporting help customers manage service delivery alongside their own operations. The study compares relevant portfolios and routes to market, separating direct product provision from technology, distribution and service roles where applicable. Strategic assessment focuses on product development, application support and market access without treating every participant as a supplier of identical offerings.

Companies Mentioned

  • Eurofins Scientific
  • Quest Diagnostics
  • Labcorp
  • BGI Genomics
  • Macrogen
  • Novogene
  • Azenta Life Sciences (GENEWIZ)
  • Fulgent Genetics
  • CD Genomics
  • Source BioScience
  • MedGenome
  • Tempus
  • NeoGenomics

Market Segmentation: Next-Generation Sequencing Services Market

By Application

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Biotechnology & Genetic Research
  • Other Applications

By Service Type

  • Human Genome Sequencing Services
  • Single Cell Sequencing Services
  • Microbial Genome-Based Sequencing Services
  • Gene Regulation Services
  • Other Service Types

By Technology

  • Sequencing-by-Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing

By End User

  • Hospitals & Clinics
  • Pharmaceutical & Biotech Companies
  • Clinical Diagnostic Laboratories
  • Academic & Research Institutions
  • Other End Users

Next-Generation Sequencing Services Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Next-Generation Sequencing Services Market Competitive Intelligence

The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analysed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across the report’s covered markets.

Countries Covered

  • North America - Next-Generation Sequencing Services Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Next-Generation Sequencing Services Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • BeNeLux
    • Russia
    • Sweden

  • Asia-Pacific - Next-Generation Sequencing Services Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Next-Generation Sequencing Services Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Next-Generation Sequencing Services Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru
* We can include data and analysis of additional countries on demand.

Research Methodology

This study combines primary inputs from industry experts across the Next-Generation Sequencing Services value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

  • What are the current market size and outlook across the covered markets?
  • Which product and customer categories offer the most relevant opportunities?
  • How do supply conditions, pricing and competitive strategies affect market development?
  • Which risks and practical investment considerations should decision makers evaluate?

Your Key Takeaways from the Next-Generation Sequencing Services Market Report

  • Global Next-Generation Sequencing Services Market size and growth projections (CAGR), 2026-2034
  • Impact of geopolitical developments on Next-Generation Sequencing Services trade, costs, and supply chains
  • Next-Generation Sequencing Services Market size, share, and outlook across the 5 regions and country/subregional markets listed above, 2026-2034
  • Next-Generation Sequencing Services Market size, CAGR, and market share of key products, applications, and end-user verticals, 2026-2034
  • Short- and long-term Next-Generation Sequencing Services Market trends, drivers, restraints, and opportunities
  • Porter’s Five Forces analysis, technological developments, and Next-Generation Sequencing Services supply chain analysis
  • Next-Generation Sequencing Services trade analysis, Next-Generation Sequencing Services Market price analysis, and Next-Generation Sequencing Services supply/demand dynamics
  • Company profiles covering business overview, key strategies, financial information where available, and relevant products
  • Latest Next-Generation Sequencing Services Market news and developments

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Next-Generation Sequencing (Ngs) Services Market Overview
2.1. Next-Generation Sequencing (Ngs) Services Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Next-Generation Sequencing (Ngs) Services Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Next-Generation Sequencing (Ngs) Services Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Next-Generation Sequencing (Ngs) Services Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Next-Generation Sequencing (Ngs) Services Market Analysis By Application, 2025-2034
5.2.1. Clinical Diagnostics
5.2.2. Drug Discovery & Development
5.2.3. Biotechnology & Genetic Research
5.2.4. Other Applications
5.3. Next-Generation Sequencing (Ngs) Services Market Analysis By Service Type, 2025-2034
5.3.1. Human Genome Sequencing Services
5.3.2. Single Cell Sequencing Services
5.3.3. Microbial Genome-Based Sequencing Services
5.3.4. Gene Regulation Services
5.3.5. Other Service Types
5.4. Next-Generation Sequencing (Ngs) Services Market Analysis By Technology, 2025-2034
5.4.1. Sequencing-by-Synthesis (SBS)
5.4.2. Ion Semiconductor Sequencing
5.4.3. Nanopore Sequencing
5.4.4. Single-Molecule Real-Time (SMRT) Sequencing
5.5. Next-Generation Sequencing (Ngs) Services Market Analysis By End User, 2025-2034
5.5.1. Hospitals & Clinics
5.5.2. Pharmaceutical & Biotech Companies
5.5.3. Clinical Diagnostic Laboratories
5.5.4. Academic & Research Institutions
5.5.5. Other End Users
6. North America Next-Generation Sequencing (Ngs) Services Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Next-Generation Sequencing (Ngs) Services Market Analysis By Application
6.3. North America Next-Generation Sequencing (Ngs) Services Market Analysis By Service Type
6.4. North America Next-Generation Sequencing (Ngs) Services Market Analysis By Technology
6.5. North America Next-Generation Sequencing (Ngs) Services Market Analysis By End User
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Next-Generation Sequencing (Ngs) Services Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Next-Generation Sequencing (Ngs) Services Market Analysis By Application
7.3. Europe Next-Generation Sequencing (Ngs) Services Market Analysis By Service Type
7.4. Europe Next-Generation Sequencing (Ngs) Services Market Analysis By Technology
7.5. Europe Next-Generation Sequencing (Ngs) Services Market Analysis By End User
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Next-Generation Sequencing (Ngs) Services Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Next-Generation Sequencing (Ngs) Services Market Analysis By Application
8.3. Asia-Pacific Next-Generation Sequencing (Ngs) Services Market Analysis By Service Type
8.4. Asia-Pacific Next-Generation Sequencing (Ngs) Services Market Analysis By Technology
8.5. Asia-Pacific Next-Generation Sequencing (Ngs) Services Market Analysis By End User
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Next-Generation Sequencing (Ngs) Services Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Next-Generation Sequencing (Ngs) Services Market Analysis By Application
9.3. Middle East and Africa Next-Generation Sequencing (Ngs) Services Market Analysis By Service Type
9.4. Middle East and Africa Next-Generation Sequencing (Ngs) Services Market Analysis By Technology
9.5. Middle East and Africa Next-Generation Sequencing (Ngs) Services Market Analysis By End User
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Next-Generation Sequencing (Ngs) Services Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Next-Generation Sequencing (Ngs) Services Market Analysis By Application
10.3. South and Central America Next-Generation Sequencing (Ngs) Services Market Analysis By Service Type
10.4. South and Central America Next-Generation Sequencing (Ngs) Services Market Analysis By Technology
10.5. South and Central America Next-Generation Sequencing (Ngs) Services Market Analysis By End User
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Next-Generation Sequencing (Ngs) Services Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Eurofins Scientific
11.2.2. Quest Diagnostics
11.2.3. Labcorp
11.2.4. BGI Genomics
11.2.5. Macrogen
11.2.6. Novogene
11.2.7. Illumina
11.2.8. Thermo Fisher Scientific
11.2.9. Azenta Life Sciences
11.2.10. Genewiz
11.2.11. Qiagen
11.2.12. Fulgent Genetics
11.2.13. CD Genomics
11.2.14. Source BioScience
11.2.15. Gene by Gene
11.2.16. MedGenome
11.2.17. Natera
11.2.18. Personalis
11.2.19. Tempus
11.2.20. NeoGenomics
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Eurofins Scientific
  • Quest Diagnostics
  • Labcorp
  • BGI Genomics
  • Macrogen
  • Novogene
  • Azenta Life Sciences (GENEWIZ)
  • Fulgent Genetics
  • CD Genomics
  • Source BioScience
  • MedGenome
  • Tempus
  • NeoGenomics

Table Information